After 25 years as one of India’s premier veterinary healthcare companies, Stallen has undergone backward integration. Stallen has recently unveiled and started operations at a new veterinary API facility in Vatva, Ahmedabad.

Stallen offers a range of feed additives, formulations and vaccines for the poultry industry and is the only company in India that manufactures every product they market. With a market presence across India, Nepal, Bangladesh and Sri Lanka along with exports in 50 countries there is an increased focus to our long term goals.

Aniket Parikh, director at Stallen with double degrees in Chemical Engineering and Biotechnology from Johns Hopkins University, USA shares the long term vision of Stallen which is a path to total self-dependence and sustainability. Given his background in chemical engineering and shared mission with our esteemed prime minister Narendra Modi on ‘Make in India’ – Stallen in focused on reducing imports and instead replacing the product range with specialty and indigenous products made in India.

In order to continue offering quality, economical prices and timely deliveries, Stallen has started production of Halquinol, a non-antibiotic growth promoter belonging to a group of hydroxy-quinolines. It is a combination of 5-chloro-8-hydroxyquinoline, 5,7-Dichloro-8-hydroxyquinoline, and 7-Chloro-8-hydroxyquinoline. The product range produced is Halquinol 98% made as per the BP 80 (British Pharmacopeia 1980) specifications. Stallen is able to sell 98% as a chemical API used in veterinary formulations and feed additives, as well as the more common 60% and 12%. Given its BP specifications and monthly increased capacity, they are now able to easily serve its global customers with valid registrations of Halquinol in more than 15 countries.

Staquinol (Halquinol 12% and 60%) is highly active against gram-positive and gram-negative bacteria, fungi, and protozoa. It has an anti-peristaltic activity that promotes the absorption of nutrients. It is proven to have no withdrawal period and resistance enabling its further use in cases when the customers are moving towards antibiotic free produce.

Stallen aims to slowly introduce a slew of APIs from this facility to reduce the dependency of products being imported from China in the animal health sector.

The facility in Vatva is the 6th addition of a manufacturing plant in Stallen’s group of companies’ manufacturing activites. The plant supplements its 2 feed additive manufacturing facilities and 2 veterinary formulation facilities in Palghar, Maharashtra along with a feed premix and additive manufacturing unit in Canada.